Cesar A. Moran, MD
Department of Pathology, University of Texas, M.D. Anderson Cancer Center, Houston

Saul Suster, MD
Department of Pathology, Medical College of Wisconsin, Milwaukee

Domenico Coppola, MD
Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida

Mark R. Wick, MD
Department of Pathology, University of Virginia at Charlottesville

Keywords: Neuroendocrine carcinoma; Lung neoplasms; Nomenclature; Classification

Upon completion of this activity, you will be able to:

• define criteria for diagnosis of different neuroendocrine tumors of the lung.
• summarize the limitations and pitfalls of the current classification of neuroendocrine tumors of the lung.
• define a panel of immunohistochemical markers that can assist in diagnosis of neuroendocrine lesions of the lung, and recognize when to apply them.